References
- Al-Aly Z. (2013). Prediction of renal end points in chronic kidney disease. Kidney Int 83:189–91.
- Astor B, Muth B, Kaufman DB, et al. (2013). Serum β2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation Kidney Int 84:810–17.
- Bolignano D, Donato V, Coppolino G, et al. (2008). Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 52:595–605.
- Bolignano D, Lacquaniti A, Coppolino G, et al. (2009). Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 4:337–44.
- Bolignano D, Coppolino G, Donato V, et al. (2010). Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? Med Sci Monit 16:RA131–5..
- Buemi A, Musuamba F, Frederic S, et al. (2014). Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation? Clin Biochem 47:68–72..
- Cernaro V, Bolignano D, Donato V, et al. (2011). NGAL is a precocious marker of therapeutic response. Curr Pharm Des 17:844–9.
- Citterlo F, Scatà MC, Violi P, et al. (2003). Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients. Transplant Proc 35:1292–4.
- Debout A, Foucher Y, Trébern-Launay K, et al. (2015). Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. Kidney Int 87:343–9.
- Gourishankar S, Grebe SO, Mueller TF. (2013). Prediction of kidney graft failure using clinical scoring tools. Clin Transplant 27:517–22.
- Haase M, Bellomo R, Devarajan P, et al. (2009). NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54:1012–24.
- Hariharan S, Johnson CP, Bresnahan BA, et al. (2000). Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605–12.
- Heyman SN, Rosenberger C, Rosen S. (2010). Experimental ischemia-reperfusion: biases and myths-the proximal vs. distal hypoxic tubular injury debate revisited. Kidney Int 77:9.
- Hollmen ME, Kyllönen LE, Inkinen KA, et al. (2011). Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int 79:89–98.
- Kahan BD. (2000). Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet 356:194–202.
- Lachenbruch PA, Rosenberg AS, Bonvini E, et al. (2004). Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design. Am J Transplant 4:451–7.
- Lacquaniti A, Buemi F, Lupica R, et al. (2013a). Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? Radiology 267:86–93..
- Lacquaniti A, Giardina M, Lucisano S, et al. (2013b). Neutrophil gelatinase-associated lipocalin (NGAL) and endothelial progenitor cells (EPCs) evaluation in aortic aneurysm repair. Curr Vasc Pharmacol 11:1001–10.
- Lacquaniti A, Donato V, Pintaudi B, et al. (2013c). “Normoalbuminuric” diabetic nephropathy: tubular damage and NGAL. Acta Diabetol 50:935–42.
- Levey AS, Bosch JP, Lewis JB, et al. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–70.
- Mallon DH, Summers DM, Bradley JA, Pettigrew GJ. (2013). Defining delayed graft function after renal transplantation: simplest is best. Transplantation 96:885–9.
- Mishra J, Ma Q, Kelly C, et al. (2006). Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 21:856–63.
- Mori K, Lee HT, Rapoport D, et al. (2005). Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia reperfusion injury. J Clin Invest 115:610.
- Neri G, Lacquaniti A, Rizzo G, et al. (2012). Real-time monitoring of breath ammonia during haemodialysis: use of ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques. Nephrol Dial Transplant 27:2945–52.
- Pennemans V, Rigo JM, Faes C, et al. (2013). Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? Clin Chem Lab Med 51:1795–802..
- Rossing P. (1998). Doubling of serum creatinine: is it sensitive and relevant? Nephrol Dial Transplant 13:244–6..
- Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. (2013). Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 28:254–73.
- Yarlagadda SG, Coca SG, Garg AX, et al. (2008). Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 23:2995.